Remove tag surgical-risk-prediction
article thumbnail

Frost & Sullivan's Top 10 predictions for healthcare in 2021

Healthcare IT News - Telehealth

The following 10 predictions that we have made for the global healthcare will define new ways of rethinking business and growth opportunities in 2021, and will help determine the future direction of the industry. In order to get new business, med-tech OEMs will be seen rolling out flexible pricing options and risk sharing models.

article thumbnail

Allurion: first HealthTech IPO of 2023 via SPAC with Compute Health

Lloyd Price

Allurion's gastric balloon is a non-surgical weight loss device that is inserted into the stomach through the mouth. Here are some of the key takeaways from Allurion's IPO: The company's gastric balloon is a non-surgical weight loss device that is FDA-approved. Additionally, the company has been criticized for its high price tag.